Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Schmidt

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Handbook of Experimental Pharmacology|December 18, 2008
Biochemical Detection of cGMP From Past to Present: An OverviewPeter M Schmidt
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2020
Technical Optimization for the High-Throughput Purification of Antibodies on Automated Liquid HandlersPeter M Schmidt
Methods in Molecular Biology (Clifton, N.J.)|May 28, 2013
Receptor binding assay for NO-independent activators of soluble guanylate cyclasePeter M Schmidt, Johannes-Peter Stasch
Analytical and Bioanalytical Chemistry|November 15, 2003
Real-time analysis on microarraysFrank F Bier, Eva Ehrentreich-Förster, Peter M Schmidt
Acta Crystallographica. Section F, Structural Biology Communications|February 5, 2019
Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalkVictor A Streltsov, Peter M Schmidt, Jennifer L McKimm-Breschkin
Biosensors & Bioelectronics|October 24, 2002
Detection of activity of telomerase in tumor cells using fiber optical biosensorsPeter M Schmidt, Christine Lehmann, Eckart Matthes, et al.
Analytical and Bioanalytical Chemistry|April 9, 2002
Determination of the turnover number of the restriction endonuclease EcoRI using evanescent wave technologyFrank F Bier, Frank Kleinjung, Peter M Schmidt, et al.
Handbook of Experimental Pharmacology|December 18, 2008
NO- and haem-independent soluble guanylate cyclase activatorsHarald H H W Schmidt, Peter M Schmidt, Johannes-Peter Stasch
Blood Cells, Molecules & Diseases|May 7, 2021
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agentMariana Ebert, Elmar Raquet, Sabine Schweisgut, et al.
Plos One|August 23, 2011
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza virusesSusan Barrett, Peter G Mohr, Peter M Schmidt, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Handbook of Experimental Pharmacology|December 18, 2008
Biochemical Detection of cGMP From Past to Present: An OverviewPeter M Schmidt
Methods in Molecular Biology (Clifton, N.J.)|October 31, 2020
Technical Optimization for the High-Throughput Purification of Antibodies on Automated Liquid HandlersPeter M Schmidt
Methods in Molecular Biology (Clifton, N.J.)|May 28, 2013
Receptor binding assay for NO-independent activators of soluble guanylate cyclasePeter M Schmidt, Johannes-Peter Stasch
Analytical and Bioanalytical Chemistry|November 15, 2003
Real-time analysis on microarraysFrank F Bier, Eva Ehrentreich-Förster, Peter M Schmidt
Acta Crystallographica. Section F, Structural Biology Communications|February 5, 2019
Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalkVictor A Streltsov, Peter M Schmidt, Jennifer L McKimm-Breschkin
Biosensors & Bioelectronics|October 24, 2002
Detection of activity of telomerase in tumor cells using fiber optical biosensorsPeter M Schmidt, Christine Lehmann, Eckart Matthes, et al.
Analytical and Bioanalytical Chemistry|April 9, 2002
Determination of the turnover number of the restriction endonuclease EcoRI using evanescent wave technologyFrank F Bier, Frank Kleinjung, Peter M Schmidt, et al.
Handbook of Experimental Pharmacology|December 18, 2008
NO- and haem-independent soluble guanylate cyclase activatorsHarald H H W Schmidt, Peter M Schmidt, Johannes-Peter Stasch
Blood Cells, Molecules & Diseases|May 7, 2021
Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agentMariana Ebert, Elmar Raquet, Sabine Schweisgut, et al.
Plos One|August 23, 2011
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza virusesSusan Barrett, Peter G Mohr, Peter M Schmidt, et al.
Pageof 3